Latest Blogs

Guest Commentary
Nov 28, 2023
Women Mentoring Women: A Thank You Note to My Two Heroes
Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.
Linda R. Duska, MD, MPH
Nov 20, 2023
The Potential of AI in Clinical Research
"We all need to stay informed and engaged on the topic of AI in order to be the best advocates for ourselves, our profession, and our patients."
International Perspectives
Nov 03, 2023
Cancer, Conflict, and Catastrophe: A Cry for Help From Sudan, a Country at War
Millions of people have been affected by the war in Sudan, and the outlook for patients with cancer is particularly dire. Dr. Nabeeha Karadawi, Dr. Salma Awad Elkareem Ali Mohamed, and Nagham Ali outline the current situation and call for immediate international aid.
Abdul-Rahman Jazieh, MD, MPH
Oct 24, 2023
Should Oncologists Continue to Be Ambivalent About Dietary Supplement Use by Their Patients?
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
Subscribe to this column

Clifford A. Hudis, MD, FASCO, FACP

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jul 25, 2013
The 2013 Breast Cancer Symposium: An Important Learning Opportunity
There are a large number of great scientific and educational meetings to choose from, but the 2013 Breast Cancer Symposium, Saturday, September 7 to Monday, September 9, in San Francisco is unique. It is big enough to draw clinical and translational experts in all disciplines and informal enough to...
Jul 21, 2013
Catch that Wave!
It has been very hot this week, and during spin class this morning—an activity of mine that Charles Sawyers managed to work into his Science of Oncology address at the 2013 ASCO Annual Meeting—my mind drifted away from the instructor’s...
Jun 03, 2013
Science and Society
The American Society of Clinical Oncology will mark its 50th year as an organization in 2014, during my term as your President. As I have thought about this upcoming year, I have tried to honor this milestone without using it as a sole focus for our organization.
1 Comments

Pages